Changes in the prevalence of self-reported sexually transmitted bacterial infections from 2010 and 2017 in two large European samples of men having sex with men-is it time to re-evaluate STI-screening as a control strategy?


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 11 11 2020
accepted: 02 03 2021
entrez: 15 3 2021
pubmed: 16 3 2021
medline: 12 10 2021
Statut: epublish

Résumé

Many European countries reported increased numbers of syphilis, gonorrhoea and chlamydia diagnoses among men who have sex with men (MSM) in recent years. Behaviour changes and increased testing are thought to drive these increases. In 2010 and 2017, two large online surveys for MSM in Europe (EMIS-2010, EMIS-2017) collected self-reported data on STI diagnoses in the previous 12 months, diagnostic procedures, STI symptoms when testing, number of sexual partners, and sexual behaviours such as condom use during the last intercourse with a non-steady partner in 46 European countries. Multivariate regression models were used to analyse factors associated with diagnoses of syphilis, gonorrhoea/chlamydia, and respective diagnoses classified as symptomatic and asymptomatic. If applicable, they included country-level screening rates. Questions on STI diagnoses and sexual behaviours were answered by 156,018 (2010) and 125,837 (2017) participants. Between 2010 and 2017, overall diagnoses with gonorrhoea/chlamydia and syphilis increased by 76% and 83% across countries. Increases were more pronounced for asymptomatic compared to symptomatic infections. The proportion of respondents screened and the frequency of screening grew considerably. Condomless anal intercourse with the last non-steady partner rose by 62%; self-reported partner numbers grew. Increased syphilis diagnoses were largely explained by behavioural changes (including more frequent screening). Gonorrhoea/chlamydia increases were mainly explained by more screening and a change in testing performance. A country variable representing the proportion of men screened for asymptomatic infection was positively associated with reporting symptomatic gonorrhoea/chlamydia, but not syphilis. The positive association of country-level screening rates with the proportion of symptomatic infections with gonorrhoea/chlamydia may indicate a paradoxical effect of screening on incidence of symptomatic infections. Treatment of asymptomatic men might render them more susceptible to new infections, while spontaneous clearance may result in reduced susceptibility. Before expanding screening programmes, evidence of the effects of screening and treatment is warranted.

Sections du résumé

BACKGROUND/OBJECTIVES
Many European countries reported increased numbers of syphilis, gonorrhoea and chlamydia diagnoses among men who have sex with men (MSM) in recent years. Behaviour changes and increased testing are thought to drive these increases.
METHODS
In 2010 and 2017, two large online surveys for MSM in Europe (EMIS-2010, EMIS-2017) collected self-reported data on STI diagnoses in the previous 12 months, diagnostic procedures, STI symptoms when testing, number of sexual partners, and sexual behaviours such as condom use during the last intercourse with a non-steady partner in 46 European countries. Multivariate regression models were used to analyse factors associated with diagnoses of syphilis, gonorrhoea/chlamydia, and respective diagnoses classified as symptomatic and asymptomatic. If applicable, they included country-level screening rates.
RESULTS
Questions on STI diagnoses and sexual behaviours were answered by 156,018 (2010) and 125,837 (2017) participants. Between 2010 and 2017, overall diagnoses with gonorrhoea/chlamydia and syphilis increased by 76% and 83% across countries. Increases were more pronounced for asymptomatic compared to symptomatic infections. The proportion of respondents screened and the frequency of screening grew considerably. Condomless anal intercourse with the last non-steady partner rose by 62%; self-reported partner numbers grew. Increased syphilis diagnoses were largely explained by behavioural changes (including more frequent screening). Gonorrhoea/chlamydia increases were mainly explained by more screening and a change in testing performance. A country variable representing the proportion of men screened for asymptomatic infection was positively associated with reporting symptomatic gonorrhoea/chlamydia, but not syphilis.
DISCUSSION/CONCLUSION
The positive association of country-level screening rates with the proportion of symptomatic infections with gonorrhoea/chlamydia may indicate a paradoxical effect of screening on incidence of symptomatic infections. Treatment of asymptomatic men might render them more susceptible to new infections, while spontaneous clearance may result in reduced susceptibility. Before expanding screening programmes, evidence of the effects of screening and treatment is warranted.

Identifiants

pubmed: 33720969
doi: 10.1371/journal.pone.0248582
pii: PONE-D-20-35441
pmc: PMC7959389
doi:

Types de publication

Clinical Trial Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0248582

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Sex Transm Dis. 2008 Jan;35(1):53-4
pubmed: 18157065
Epidemiol Infect. 2019 Jan;147:e143
pubmed: 30869043
Clin Infect Dis. 2021 Jan 30;:
pubmed: 33513222
Sex Transm Infect. 2007 Jul;83(4):324-6
pubmed: 17591663
Sex Transm Infect. 2013 Nov;89(7):575-82
pubmed: 23744961
BMC Public Health. 2016 Oct 22;16(1):1111
pubmed: 27770775
Theor Popul Biol. 2014 May;93:52-62
pubmed: 24513099
J Infect Dis. 2010 Jun 15;201 Suppl 2:S104-13
pubmed: 20470048
AIDS. 2010 Jul 31;24(12):1799-812
pubmed: 20601854
Swiss Med Wkly. 2020 Dec 31;150:w20392
pubmed: 33382077
Sex Transm Infect. 2007 Apr;83(2):106-12
pubmed: 17020893
Euro Surveill. 2015 Apr 16;20(15):
pubmed: 25953130
Clin Infect Dis. 2020 Aug 22;71(5):1243-1247
pubmed: 31560366
Clin Infect Dis. 2004 Oct 1;39(7):996-1003
pubmed: 15472852
J Int AIDS Soc. 2019 Aug;22 Suppl 6:e25354
pubmed: 31468730
Sex Transm Infect. 2014 Feb;90(1):46-51
pubmed: 23920398
Int J STD AIDS. 2020 Jan;31(1):69-76
pubmed: 31842695
Sex Transm Dis. 2004 Mar;31(3):154-60
pubmed: 15076927
Sex Transm Infect. 2010 Apr;86(2):90-6
pubmed: 19841003
Sex Transm Infect. 2016 Mar;92(2):155-60
pubmed: 26297719
Sex Transm Dis. 2006 Jan;33(1):36-51
pubmed: 16385221
Clin Infect Dis. 2020 Dec 3;71(9):e399-e405
pubmed: 31967644
Sex Transm Infect. 2008 Oct;84 Suppl 2:ii4-11
pubmed: 18799491
Sex Transm Dis. 2020 Oct 8;:
pubmed: 33044378
Clin Infect Dis. 2020 Sep 02;:
pubmed: 32877526
Sex Health. 2016 Jun;13(3):199-204
pubmed: 26886136
Arch Sex Behav. 2018 Oct;47(7):1909-1922
pubmed: 29270705
Sex Transm Infect. 2020 Nov 3;:
pubmed: 33144345
Sex Transm Dis. 2016 Feb;43(2):71-77
pubmed: 26760178
J Urban Health. 2016 Apr;93(2):400-6
pubmed: 27055446
Clin Infect Dis. 2017 Sep 1;65(5):712-718
pubmed: 28505240
Euro Surveill. 2010 Sep 30;15(39):19673
pubmed: 20929655
J Acquir Immune Defic Syndr. 2019 May 1;81(1):52-56
pubmed: 30768489
Euro Surveill. 2006 Sep;11(9):146-8
pubmed: 17075163
Sex Transm Infect. 2008 Oct;84(5):361-3
pubmed: 18596068
Sex Transm Infect. 2020 Dec;96(8):556-561
pubmed: 32732336
Gastroenterology. 2009 May;136(5):1609-17
pubmed: 19422083
JAMA. 2019 Apr 9;321(14):1380-1390
pubmed: 30964528
Sex Transm Infect. 2020 Nov;96(7):537-540
pubmed: 32066589

Auteurs

Ulrich Marcus (U)

Department for Infectious Diseases Epidemiology, Robert Koch Institute, Berlin, Germany.

Massimo Mirandola (M)

Department of Diagnostics and Public Health, Infectious Diseases Section, University of Verona, Verona, Italy.

Susanne B Schink (SB)

Department for Infectious Diseases Epidemiology, Robert Koch Institute, Berlin, Germany.

Lorenzo Gios (L)

Department of Diagnostics and Public Health, Infectious Diseases Section, University of Verona, Verona, Italy.

Axel J Schmidt (AJ)

Sigma Research, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Division of Infectious Diseases, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH